-
MPACT OF GLUCAGON-LIKE PEPTIDE-1 (GLP-1) AGONISTS TO TREAT OBESITY ON NON-GLP-1 COSTS AMONG COMMERCIALLY INSURED MEMBERS WITHOUT DIABETES: A THREE-YEAR RETROSPECTIVE ANALYSIS
Mar 18, 2026, 21:38 PM -
CAR-TUTILIZATION BEFORE AND AFTER THE APPROVAL AS A SECOND-LINE THERAPY FOR DIFFUSE LARGE B-CELL LYMPHOMA PATIENTS: AN INTERRUPTED TIME SERIES ANALYSIS
Mar 18, 2026, 21:38 PM -
GEOGRAPHIC MAPPING OF CANCER INCIDENCE IN DENMARK: IDENTIFYING POTENTIAL FOR DECENTRALIZED ONCOLOGY CARE IN LUNG CANCER CARE (HEATMAP-ONCO-LUNG)
Mar 18, 2026, 21:38 PM -
ENHANCING LONG-TERM COST-EFFECTIVENESS PROJECTIONS USING REAL-WORLD EVIDENCE-INFORMED UNCERTAINTY ANALYSIS
Mar 18, 2026, 21:38 PM -
AI-ENABLED VIRTUAL REALITY REHABILITATION: A HEALTH ECONOMIC FRAMEWORK FOR NEURO-ONCOLOGY
Mar 18, 2026, 21:38 PM -
MODELLING THE COST-EFFECTIVENESS PROFILE OF RAPID GENOME SEQUENCING IN CHILDREN SUSPECTED OF RARE GENETIC DISEASES
Mar 18, 2026, 21:38 PM -
GLP-1 RECEPTOR AGONIST-ASSOCIATED THROMBOCYTOPENIA: A NOVEL/EXTENSIVE PHARMACOVIGILANCE EVALUATION FROM SOUTHERN NETWORK ON ADVERSE REACTIONS (SONAR-AI)
Mar 18, 2026, 21:38 PM -
A U.S. BURDEN OF DISEASE PROJECTION MODEL FOR NON-OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY, 2027-2035
Mar 18, 2026, 21:38 PM -
EVALUATION OF THE PCPA NEGOTIATION TIMELINE PROCESS FOR BRANDED NON ONCOLOGY DRUGS IN CANADA
Mar 18, 2026, 21:38 PM -
BUILDING HIGH-QUALITY, RESEARCH-GRADE MULTI-SOURCE MORTALITY DATABASES IN A TIMELY MANNER
Mar 18, 2026, 21:38 PM -
COST-EFFECTIVENESS OF PSILOCYBIN-ASSISTED THERAPY (PAT) FOR PATIENTS WITH TREATMENT-RESISTANT DEPRESSION
Mar 18, 2026, 21:38 PM -
COST-CONSEQUENCE MODEL OF WHOLE-EXOME, WHOLE-TRANSCRIPTOME SEQUENCING VERSUS 50-GENE PANELS FOR GENOMIC PROFILING IN ADVANCED SOLID TUMORS
Mar 18, 2026, 21:38 PM -
INITIATION WITH GLP-1 RECEPTOR AGONISTS TREATMENT FOR OBESITY IN PATIENTS WITH MENTAL HEALTH CONDITIONS - A REAL WORLD DATA RETROSPECTIVE STUDY
Mar 18, 2026, 21:38 PM -
SCOPING REVIEW OF REMOTE PATIENT MONITORING SOLUTIONS USING SENSOR-BASED TECHNOLOGIES IN ONCOLOGY CARE
Mar 18, 2026, 21:38 PM -
COMPARING ESTABLISHED AND NOVEL INDEX DATE SELECTION METHODS: A SIMULATION STUDY IN TWO CLINICAL CONTEXTS
Mar 18, 2026, 21:38 PM -
STUDENT-REPORTED BARRIERS TO ISPOR CONFERENCE ATTENDANCE: A NORTH AMERICA VS. REST OF WORLD ANALYSIS
Mar 18, 2026, 21:38 PM -
SAME EVIDENCE, DIFFERENT DECISIONS: HOW REGULATORY STANDARDS SHAPE ORPHAN DRUG APPROVALS
Mar 18, 2026, 21:38 PM -
FACTORS INFLUENCING HEALTHCARE COSTS FOR LITHOTRIPSY: ANALYSIS USING PREMIER HEALTHCARE DATA (PINC™ AI)
Mar 18, 2026, 21:38 PM -
HEALTHCARE RESOURCE UTILIZATION AMONG PEOPLE LIVING WITH HIV BEFORE AND AFTER THE COVID-19 PANDEMIC IN THE UNITED STATES: A DESCRIPTIVE ANALYSIS
Mar 18, 2026, 21:38 PM -
REAL WORLD DATA COMPARATIVE EFFECTIVENESS STUDY OF A BILAYERED LIVING CELLULAR CONSTRUCT AND A CRYOPRESERVED CADAVERIC SKIN ALLOGRAFT FOR THE TREATMENT OF PRESSURE INJURIES
Mar 18, 2026, 21:38 PM
